Fundraising FoxLongitude Capital — 2017 Investments
6 investments dated 2017 · listed companies and verified rows first · show all
Boston Scientific develops medical devices and technologies used by healthcare professionals to treat patients across a range of conditions.
HealthtechMedical DevicesIrvine, US
Michael Williamson(Executive Officer)Dan L. Dearen(Executive Officer)inRaymond Cohen(Executive Officer, Director)in
BoardDarren Cai(Director)Raphael Wisniewski(Director)Erik Amble(Director)
Board seatBakker· per SEC Form D
Co-investorsAdvent Life SciencesAndera PartnersGilde Healthcare
Amphora provides logistics services aimed at supporting business growth and operational efficiency.
E-commerceLogistics & Supply ChainSaaS
Joan Tresserras(Founder)inAdrià Cortés(Founder)in
Co-investorsBStartupBaird CapitalF-Prime CapitalHBM Healthcare Investments
Predictive Oncology (POAI) operates an AI/ML platform powered by a biobank of over 150,000 tumor samples across 137 cancer types to predict tumor-drug response for oncology drug discovery.
AI & Machine LearningBiotechHealthtechPittsburgh, US
GERALD J. VARDZEL JR.(Executive Officer, Director)DOUGLAS ARMSTRONG(Executive Officer, Director)
BoardROBERT D. KEYSER JR.(Director)RICHARD AULICINO(Director)
WelbeHealth operates a Program of All-Inclusive Care for the Elderly (PACE) that provides integrated medical and social services to seniors, including primary care, dental, vision, hearing, in-home care, transportation, and social activities.
Digital HealthHealthtechWellness & FitnessCalifornia, US
Si France, MD(Founder)inCLANCY SI FRANCE(MANAGER AND CHIEF EXECUTIVE OFFICER OF ISSUER)
BoardLIAM DONOHUE(MANAGER OF ISSUER)inADAM GROFF(MANAGER OF ISSUER)inMICHAEL ZUBKOFF(MANAGER OF ISSUER)JONATHAN LIM(MANAGER OF ISSUER)
Co-investors.406 VenturesAlumni VenturesF-Prime CapitalGeneral AtlanticTown Hall Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.